furazolidone-based quadruple therapy for eradication of helicobacter pylori infection in peptic ulcer disease
نویسندگان
چکیده
background helicobacter pylori is the main pathogenic factor for chronic gastritis and peptic ulcer disease. therefore, its successful eradication is important in the disease management. multiple first-line treatments have been employed; the eradication rates in the most successful regimens have been 75%-92%. primary bacterial resistance to antibiotics and patient compliance are two main cause of therapy failure. furazolidone with a broad spectrum of antimicrobial activities is widely used in the treatment of bacterial and protozoal infections in both humans and animals, which could also be used in treatment of h. pylori infection. objectives this study was designed to evaluate the efficacy of the therapeutic regimen containing furazolidone in comparison with a standard regimen against h. pylori. materials and methods in this randomized clinical trial, 110 patients with a positive urease breath test (ubt) were selected and randomly divided into two equal groups. the first group received the standard regimen consisting of clarithromycin (500 mg q12h), amoxicillin (1 g q12) and a proton pump inhibitor (ppi) (omeprazole 20 mg bid). the second group received bismuth subcitrate (120 mg q6h), furazolidone (100 mg q6h) and tetracycline (250 mg q6h) and a ppi (omeprazole 20 mg bid) for two weeks. ubt was performed again for all the patients two months after completing. results ubt was negative in 83.6% of patients in the standard group two months after the end of the treatment. eradication of h. pylori was reported in 94.5% of patients in the experimental group. no significant relationship between age and eradication of h. pylori was observed in both groups. nausea and vomiting was reported in 5.45% of patients treated with our experimental regimen. these symptoms were tolerable and the treatment was completely continued. no adverse effect was recorded in the standard group. moreover, no relationship was observed between gender and eradication of h. pylori in both groups. finally, despite a better therapeutic response to our experimental group in comparison with the standard one, no statistically significant difference was observed (p = 0.067). conclusions based on our finding in this study and similar studies in different parts of the world, furazolidone could be prescribed as an effective antibiotic against h. pylori in patients with gastritis.
منابع مشابه
A furazolidone-based quadruple therapy for Helicobacter pylori retreatment in patients with peptic ulcer disease.
PURPOSE Many of the currently used eradication regimens against Helicobacter pylori fail to cure the infection either due to antimicrobial resistance or to poor patient compliance. The infection leads to increased risk of developing potentially severe complications, such as gastric cancer. This study was aimed at assessing the efficacy and safety of a quadruple therapy with furazolidone for H. ...
متن کاملComparison between the effectiveness of Furazolidone and Clarithromycin on eradication of helicobacter pylori among patients with peptic ulcer
Introduction: Helicobacter pylori infections occur in about 50% of the world population and have a main role in the creation of peptic ulcer and its related cancer. We sought to evaluate the effectiveness of two treatment regimens on the eradication of helicobacter pylori and its complications among peptic ulcer patients. Materials and methods: By a clinical trial, patients with peptic ulcer ...
متن کاملThe efficacy of furazolidone-based quadruple therapy for eradication of Helicobacter pylori infection in Iranian patients resistant to metronidazole-based quadruple therapy.
BACKGROUND Furazolidone has recently shown promising efficacy in H. pylori eradication and has replaced metronidazole in different eradication regimens especially in countries, like Iran, with high prevalence of metronidazole resistance and where clarithromycin is expensive and hardly available. This study tries to determine the efficacy of a quadruple therapy based on furazolidone as a second ...
متن کاملefficacy of standard triple therapy versus bismuth-based quadruple therapy for eradication of helicobacter pylori infection
helicobacter pylori is the main cause of gastric ulcer, adenocarcinoma and mucosa-associated lymphoid tissue (malt) lymphoma. up to now, different regimens have been used for helicobacter pylori (h.pylori) eradication to find the most potent and cost-effective regimen with less side effects. the aim of this study was to investigate the efficacy of standard triple therapy versus quadruple therap...
متن کاملEradication therapy for peptic ulcer disease in Helicobacter pylori positive patients.
BACKGROUND Peptic ulcer disease is the cause for dyspepsia in about 10% of patients. 95% of duodenal and 70% of gastric ulcers are associated with Helicobacter pylori. Eradication of H pylori reduces the relapse rate of ulcers but the magnitude of this effect is uncertain. OBJECTIVES The primary outcomes were the proportion of peptic ulcers healed initially and proportion of patients free fro...
متن کاملمنابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
archives of clinical infectious diseasesجلد ۹، شماره ۳، صفحات ۰-۰
کلمات کلیدی
میزبانی شده توسط پلتفرم ابری doprax.com
copyright © 2015-2023